Factores asociados a bajo rendimiento cognitivo en adultos con sospecha de apnea obstructiva del sueño / Factors associated with low cognitive performance in adults with suspected obstructive sleep apnea

La apnea obstructiva del sueño (AOS) se ha asociado a deterioro cognitivo. OBJETIVO: Identificar factores asociados a bajo rendimiento cognitivo (BRC) en adultos con sospecha de AOS. MÉTODO: Se realizó evaluación cognitiva empleando la Evaluación Cognitiva de Montreal (MoCA); se consideró BRC un puntaje inferior a 21. El diagnóstico de AOS fue mediante poligrafía respiratoria de 5 canales, según índice de apnea-hipopnea (IAH). Se evaluó también calidad de sueño, síntomas depresivos, entre otros. RESULTADOS: En 91,5% de 320 pacientes consecutivos se confirmó el diagnóstico de AOS. El promedio de MoCA fue 20,6 puntos. El grupo con BRC tenía mayor edad, menor escolaridad; mayor frecuencia de hipertensión arterial y diabetes mellitus, y desaturaciones de la oxihemoglobina de mayor magnitud. No hubo diferencias de gravedad según IAH entre ambos grupos. COMENTARIO: Los pacientes con BRC presentan factores de riesgo asociados a deterioro cognitivo, y mayor magnitud de desaturaciones de la oxihemoglobina.

Obstructive sleep apnea (OSA) has been associated with cognitive decline. OBJECTIVE: To identify factors associated with low cognitive performance (LCP) in adults with suspected OSA. MATHOD: Cognitive evaluation was performed using Montreal Cognitive Assessment (MoCA), and scores lower than 21 were considered LCP. The diagnosis of OSA was made using 5-channel respiratory polygraphy, according to the apnea-hypopnea index (AHI). Sleep quality, depressive symptoms, among others, were also evaluated. RESULTS: In 91.5% of 320 consecutive patients the diagnosis of OSA was confirmed. The MoCA average was 20.6 points. The group with LCP was older, less educated, were more likely to have hypertension and diabetes mellitus, and with more severe oxyhemoblobin desaturations. There were no differences in severity according to AHI between both groups. COMMENT: Patients with LCP have risk factors associated with cognitive impairment, besides more severe oxyhemoglobin desaturations.

Neurotoxicidad secundaria a metronidazol: un efecto adverso reversible. Caso clínico / Reversible neurotoxicity secondary to metronidazole report of one case

Metronidazole can cause adverse effects both in the central and peripheral nervous system. We report a 34-year-old female who presented a reversible cerebellar syndrome and peripheral neuropathy as an adverse effect associated with the use of metronidazole. Brain magnetic resonance imaging (MRI) showed hyperintense T2 and FLAIR bilateral symmetrical cerebellar lesions, without contrast enhancement or mass effect, isointense in diffusion-weighted imaging and hypointense in apparent diffusion coefficient sequences. Also, electrophysiological evaluation was consistent with axonal polyneuropathy. She had received metronidazole for a liver abscess during 49 days. After discontinuation of metronidazole, she had rapid regression of cerebellar symptoms and normalization of MRI, with subsequent disappearance of peripheral symptoms. The brain MRI, electromyography and nerve conduction studies performed at 35 months later showed complete resolution of the lesions. Although metronidazole neurotoxicity is a rare event, it must be borne in mind because the prognosis is usually favorable after stopping the drug.